Young Research & Publishing Inc.

Investment Research Since 1978

Disclosure

  • About Us
    • Contributors
    • Archives
    • Dick Young’s Safe America
    • The Final Richard C. Young’s Intelligence Report
    • You’ve Read The Last Issue of Intelligence Report, Now What?
    • Dick Young’s Research Key: Anecdotal Evidence Gathering
    • Crisis at Vanguard
  • Investment Analysis
    • Bonds
    • Currencies and Gold
    • Dividend Investing
    • ETFs & Funds
    • Investment Strategy
    • Retirement Investing
    • Stocks
    • The Efficient Frontier
  • Investment Counsel
  • Dynamic Maximizers®
  • Retirement Compounders®
  • Free Email Signup

Is CVS Pioneering a Revolution in Dialysis?

August 1, 2019 By Jeremy Jones, CFA

By Aleksandr Ivasenko @ Shutterstock.com

It’s not often a drug store/insurance company begins building its own medical devices. In fact, this may be a first. CVS is testing its own home dialysis machine. The machine could make the process of dialysis easier for the nearly 500,000 Americans on dialysis. Anna Wilde Mathews reports at The Wall Street Journal:

CVS Health Corp. CVS -1.17% is making an ambitious move into kidney care, launching a clinical trial for a new home-dialysis device designed by the firm of Dean Kamen, the Segway inventor.

The company is delving into unusual territory for a drugstore and health insurer. The plan will make it a medical-device firm and a provider of dialysis, the complex blood-cleansing procedure vital to patients suffering from kidney failure. CVS holds exclusive U.S. rights to the HemoCare device, which was created by Mr. Kamen’s firm, Deka Research & Development Corp.

CVS will work to capitalize on an initiative announced last week by the Trump administration, which wants to move more dialysis into the home, rather than dialysis centers, where most U.S. patients currently get the procedure. Dialysis is covered by Medicare, including for patients under the age of 65. The care of patients with end-stage renal disease is a major cost for the program, amounting to around $35 billion in 2016, or roughly 7% of total spending under traditional Medicare.

The Department of Health and Human Services said increased use of home dialysis could reduce costs and “preserve or enhance the quality of care.”

Alan Lotvin, executive vice president at CVS, said the company is making a broader push into care for patients with kidney disease, including managing the care of those who aren’t yet eligible for dialysis. CVS plans to offer home dialysis services, both using the new device and a different method known as peritoneal dialysis, but it doesn’t expect to perform dialysis in its own facilities or stores, he said. The new device is expected to be leased or sold to other providers, he said.

“We think that this is a really important step forward for the care of patients,” Dr. Lotvin said.

Read more here.

Share this:

  • Email
  • Twitter
  • Facebook

You Might Also Like:

  • The Fourth Industrial Revolution?
  • CVS Blasts Amazon with Next Day Prescription Delivery
  • Is the Quantum Revolution Imminent?
  • Author
  • Recent Posts
Jeremy Jones, CFA
Jeremy Jones, CFA, CFP® is the Director of Research at Young Research & Publishing Inc., and the Chief Investment Officer at Richard C. Young & Co., Ltd. Richard C. Young & Co., Ltd. was ranked #5 in CNBC's 2021 Financial Advisor Top 100. Jeremy is also a contributing editor of youngresearch.com.
Latest posts by Jeremy Jones, CFA (see all)
  • Resilient Nordic Market Spawns Fast Growing Offshoot - August 9, 2022
  • SHOCK: Home Prices FALL in San Francisco as Market Dries Up - August 8, 2022
  • Despite All the Money Involved, Crypto Is Still a Wild Market - August 5, 2022

Search Young Research

Most Popular

  • The Key Ingredient to an $8 Million Estate Is This
  • SCHUMER-MANCHIN: An "Inflation" Bill that Doesn't Fight Inflation
  • The Power of a Compound Interest Table
  • NO GO ZONES: The Wealthy Protected, the Rest Left to Rot
  • Vanguard Wellesley (VWINX) vs. Wellington (VWELX): Which Fund is Best?
  • Do Governments Cause Recessions On Purpose?
  • Do You Have $500,000 in Savings? Avoid This Nightmare
  • American Manufacturers ALARMED by Schumer-Manchin Tax Hike Plan
  • Corporate Bond Yields: What You Can Earn Today
  • Field of Dreams: You Too Can Live Like a Billionaire

Don’t Miss

Default Risk Among the Many Concerns with Annuities

Risk and Reward: An Efficient Frontier

How to be a Billionaire: Proven Strategies from the Titans of Wealth

Could this Be the Vanguard GNMA Winning Edge?

Cryptocosm and Life After Google

Warning: Avoid Mutual Fund Year End Distributions

Is Gold a Good Long-term Investment?

How to Invest in Gold

Vanguard Wellington (VWELX): The Original Balanced Fund

What is the Best Gold ETF for Investing and Trading?

Procter & Gamble (PG) Stock: The Only True Dividend King

The Dividend King of the North

You’ll Love This if You’re Dreaming of an Active Retirement Life

RSS The Latest at Richardcyoung.com

  • Pelosi’s Trip a “Pointless Gesture That Brought Us Closer to Military Conflict”
  • RIP David McCullough
  • Your Retirement Life: Let the Slow and Steady Be Your Way of LIFE
  • Who Benefits from and Orchestrated the Trump Raid?
  • California’s Progressive Liberals Have Created a Monster
  • DeSantis Leadership: Good Government and Smart Politics
  • The Most Vulnerable Will Suffer at the Hands of Anthony Fauci
  • If the Phone Doesn’t Ring…It’s Me
  • REGION AT RISK? Chaos of War Surrounds Ukrainian Nuclear Plant
  • Did China Buy Land in North Dakota to Spy on Air Force Base?

About Us

  • About Young Research
  • Archives
  • Contributors

Our Partners

  • Richard C. Young & Co.
  • Richardcyoung.com

Copyright © 2022 | Terms & Conditions

 

Loading Comments...
 

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.